Dr. Arthur Michael Cotliar, MD

Dr. Cotliar practices at Eye Surgery Center of Westchester in New Rochelle, New York.

Dr. Cotliar's NPI, 1992770630, was assigned on February 17, 2006. Dr. Cotliar graduated from Albert Einstein College of Medicine in 1978. Dr. Cotliar holds New York license 136628.

Dr. Cotliar's primary practice is Eye Surgery Center of Westchester, at 838 Pelhamdale Road, New Rochelle, NY 10801. The practice phone is (914) 626-9600.

Dr. Cotliar's primary practice is Eye Surgery Center of Westchester in New Rochelle, New York. Dmand AI also links Dr. Cotliar to 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cotliar practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Cotliar's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Cotliar is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Cotliar's licenses on file in 2 states: New York and Florida.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eyelid inflammation, glaucoma and glaucoma surgery among the conditions Dr. Cotliar treats.

CMS data shows 2,460 Medicare services from Dr. Cotliar across 18 procedure codes in 2024, for 756 Medicare patients. Medicare paid $246,422 for them.

CMS counts 756 Medicare patients who saw Dr. Cotliar in 2024. The largest group is 75 to 84, with 323 patients. 74% of them have high cholesterol, and 69% have high blood pressure. 24% are also on Medicaid. Their average risk score is 1.13, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Cotliar's median patient age at 71, with 57% women.

In 2024, Dr. Cotliar wrote 9,075 Medicare Part D claims for 2,063 patients. 51% of them were for generic drugs. CMS names the drug for 8,905 of them, across 40 drugs with 11 or more claims each, at $1,901,080 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Cotliar for performance year 2024, reported as part of a group. Dr. Cotliar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 310 procedures of cataract surgery by Dr. Cotliar, more than 90% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Dr. Cotliar. Dr. Cotliar has published most often in J Cataract Refract Surg. Dr. Cotliar's most frequent co-authors are Richard E. Braunstein, MD, Allan H. Friedman, MD and Baruch David Gorman, MD.

CMS Open Payments shows 85 general payments to Dr. Cotliar from 14 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Alcon Laboratories Inc paid the most, $1,198.

Dmand AI lists 4 awards for Dr. Cotliar, most recently CMS Stage 1 2012 in 2012.

Dr. Cotliar graduated from Albert Einstein College of Medicine in 1978. Dr. Cotliar is a member of AAO.

Dr. Cotliar is in network with 23 carriers, including Aetna, United Healthcare and HCSC. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.